Hoffmann-La Roche: Colorectal Neoplasms trials

The registry lists 111 Colorectal Neoplasms studies with Hoffmann-La Roche as lead sponsor. 3 are open to participants now and 52 have results posted.

Phase 1 25Phase 2 35Phase 3 15Phase 4 8No phase 31(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)CompletedNCT00497497Phase 1
• A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES)CompletedNCT00388206
• Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal CancerCompletedNCT00345761Phase 1/2
• A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal CancerTerminatedNCT00114946Phase 4
• A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal CancerCompletedNCT00109226Phase 2
• A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal CancerCompletedNCT00109070Phase 3
• A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal AdenocarcinomaCompletedNCT00097578
• A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer StudyCompletedNCT00096967Phase 3
• A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal CancerCompletedNCT00048139Phase 2
• A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal CancerCompletedNCT00048126Phase 2
• Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal CancerCompletedNCT00047762Phase 1